Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Front Epidemiol ; 4: 1368675, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38952354

RESUMO

Background: Multiple Sclerosis (MS) is a common neurological disease among white populations of European origin. Frequencies among Latin Americans continue to be studied, however, epidemiologic, and clinical characterization studies lack from Central American and Caribbean countries. Ethnicity in these countries is uniformly similar with a prevalent Mestizo population. Methods and results: Data from January 2014 to December 2019 from Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panama, Dominican Republic, and Aruba on demographic, clinical, MRI and phenotypic traits were determined in coordinated studies: ENHANCE, a population-based, retrospective, observational study on incidence and clinical characteristics, and from the subgroup with MS national registries (Aruba, Dominican Republic, Honduras, and Panama), data on prevalence, phenotypes and demographics. Expanded Disability Status Scale (EDSS), and therapeutic schemes were included. ENHANCE data from 758 patients disclosed 79.8% of Mestizo ethnicity; 72.4% female; median age at onset 31.0 years and 33.2 at diagnosis. The highest incidence rate was from Aruba, 2.3-3.5 × 100,000 inhabitants, and the lowest, 0.07-0.15 × 100,000, from Honduras. Crude prevalence rates per 100,000 inhabitants fluctuated from 27.3 (Aruba) to 1.0 (Honduras). Relapsing MS accounted for 87.4% of cases; EDSS <3.0 determined in 66.6% (mean disease duration: 9.1 years, SD ± 5.0); CSF oligoclonal bands 85.7%, and 87% of subjects hydroxyvitamin D deficient. Common initial therapies were interferon and fingolimod. Switching from interferon to fingolimod was the most common escalation step. The COVID-19 pandemic affected follow-up aspects of these studies. Conclusion: This is the first study providing data on frequencies and clinical characteristics from 8 countries from the Central American and Caribbean region, addressing MS as an emergent epidemiologic disorder. More studies from these areas are encouraged.

2.
PLoS One ; 13(10): e0204681, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30304006

RESUMO

The purpose of this work is to estimate the costs associated with managing patients with MS in Panama and evaluating the impact of the disease on their health-related quality of life (HRQoL). Multicentric observational, retrospective, cross-sectional study. The costs were estimated from societal and patient perspectives and expressed in USD, 2015. The focus of the study is based on prevalence and on a "bottom-up" approach. To estimate the total cost per patient, annual reported use for each resource was multiplied by its unit cost. To evaluate HRQoL, patients completed the EQ-5D-3L questionnaire. 108 patients took part in the study. 82.41% were women with 44.78 (SD: 12.27) years. 61.11% presented mild (EDSS = 0-3.5), 25.93% moderate (EDSS = 3.5-6) and 12.96%, severe disability (EDSS≥6.5). The mean annual cost from the patient's perspective was estimated at 777.99 USD (SD: 1,741.45) per patient. The mean cost from a societal perspective was estimated at 23,803.21 USD (SD: 13,331.83) per patient. Disease-modifying therapies (DMT) accounted for the main component of the cost. A deterioration in HRQoL was observed as the disease advances and as disability increases, with mobility and usual activities being the areas most affected by its progression. From both perspective, the cost per MS patient in Panama is high. In addition to the high economic impact, MS also exerts a negative impact on patient HRQoL, which increases as the disease advances.


Assuntos
Efeitos Psicossociais da Doença , Esclerose Múltipla/economia , Adulto , Estudos Transversais , Progressão da Doença , Feminino , Custos de Cuidados de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/epidemiologia , Esclerose Múltipla/terapia , Panamá/epidemiologia , Qualidade de Vida , Estudos Retrospectivos , Inquéritos e Questionários
3.
Cogitare enferm ; 13(4): 558-565, out.-dez. 2008.
Artigo em Português | LILACS, BDENF - Enfermagem | ID: lil-520941

RESUMO

A Educação à Distância (EAD) vem se constituindo como uma estratégia concreta e eficaz para formação de profissionais. Os objetivos deste estudo foram: identificar experiências anteriores dos enfermeiros com EAD; identificar se há interesse dos enfermeiros em participar de cursos de EAD; e apreender com os enfermeiros sugestões de temas para os cursos de EAD. Os resultados mostraram que a maioria (59 por cento) tinha título de especialista e trabalhava há mais de 10 anos na assistência perioperatória (41 por cento). Observou-se que 88 por cento possuíam computador em casa e 100 por cento deles tinham acesso à internet, no entanto, apenas 35 por cento a utilizavam. Quanto à experiência com EAD 53 por cento disseram não ter nenhuma experiência. A maioria dos participantes (88 por cento) interessou-se na abertura de cursos de EAD e fizeram várias sugestões de temas.


Assuntos
Centro Cirúrgico Hospitalar , Educação Continuada em Enfermagem , Educação a Distância , Enfermagem Perioperatória , Enfermeiras e Enfermeiros , Enfermeiros , Pessoal de Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA